New Novartis data in relapsing MS reinforce benefits of Kesimpta for first-line and switch patients: Basel Friday, September 20, 2024, 12:00 Hrs [IST] Novartis announced new data ...

Oral Controlled Release Drug Delivery Technology Market is anticipated to reach a valuation of about USD 68.4 billion by 2032 ...

Today, the Lonza Board of Directors announced the nomination of Juan Andres and Eric Drapé as Independent Members of the Board. The Board will propose to shareholders the election of both nominees at ...

Novartis is making two investments in new radiopharmaceutical manufacturing sites in the US. The Swiss pharmaceutical giant will open a third US radioligand plant in Carlsbad, California, to serve the ...

Issuance is expected to increase before the US election, after several borrowers decided to come to market in advance of the ...

Bausch Health is rumored to be looking to sell its Bausch + Lomb business, which will ease bankruptcy concerns and upgrade ...

Today, the Family Heart Foundation®, a leading research and advocacy organization, announced the successful completion of the Flag, Identify, Network and Deliver™ “FIND Lp(a)” machine learning model – ...

Bank of America is the national presenting sponsor and Walgreens, Novartis and Lilly are national series sponsors for the MORE THAN PINK Walk and Race for the Cure events. Join us at the San Antonio ...

The decision to use b/tsDMARD monotherapy vs combination therapy with MTX when treating PsA is primarily based on patient satisfaction and drug tolerability.

Time spent above, not below, the target glucose range was associated with mortality in a study of adults with type 2 diabetes ...

Susac syndrome is a rare inflammatory vascular endotheliopathy affecting the small vessels of the brain, eye, and ear.1,2 ...

The Meal Recovery Coalition (MRC), a groundbreaking coalition across the private and nonprofit sectors, officially launched ...